A Heart Rate Monitoring App (FibriCheck) for Atrial Fibrillation in General Practice: Pilot Usability Study

Simon Gabriël Beerten, Tine Proesmans, Bert Vaes, Simon Gabriël Beerten, Tine Proesmans, Bert Vaes

Abstract

Background: Atrial fibrillation (AF) is a major risk factor for stroke. The current opportunistic screening procedure consists of pulse palpation and an electrocardiogram when an irregular rhythm is found. Smartphone apps that measure heart rhythm could be useful in increasing the detection of AF in a primary care setting.

Objective: We conducted a pilot study with the smartphone app FibriCheck to assess whether the introduction of such an app is feasible.

Methods: Four general practices across Flanders provided patient data for the study. Inclusion criteria for participants were aged 65 or older and a CHARGE-AF score of at least 10%. We excluded patients with known AF or a pacemaker. Participants were asked to measure at least twice a day with FibriCheck (for at least 14 days). They were provided the 36-Item Short Form Survey (SF-36) questionnaire both before and after the study, as well as different surveys concerning their user experience and general perception of technology.

Results: There were 92 participants (36 women and 56 men). The study population was relatively homogenous concerning risk factors and medication use at baseline. During the study period, 5/86 (6%) participants were found to have AF (6 dropouts). The average study period was 23 days and the average number of measurements per day was 2.1. Patient compliance was variable, but high. On the whole, there were no appreciable changes in quality of life. The overall user experience and satisfaction were very high.

Conclusions: FibriCheck is a relatively easy-to-use smartphone app to complement AF screening in primary care. Its implementation in this setting is certainly achievable, and one can expect high rates of patient compliance. Based on these results, a planned cluster randomized trial will be going ahead.

Trial registration: ClinicalTrials.gov NCT03509493; https://ichgcp.net/clinical-trials-registry/NCT03509493.

Keywords: FibriCheck; atrial fibrillation; primary care; smartphone app.

Conflict of interest statement

Conflicts of Interest: TP is an employee of Qompium, the study’s funder. Other authors declare no conflicts of interest.

©Simon Gabriël Beerten, Tine Proesmans, Bert Vaes. Originally published in JMIR Formative Research (http://formative.jmir.org), 07.04.2021.

Figures

Figure 1
Figure 1
Average number of measurements per day, per participant.
Figure 2
Figure 2
Proportion of reported symptoms (N=4449); 40 measurements were not validated by the algorithm due to connection errors.
Figure 3
Figure 3
Number of different FibriCheck measurements (N=4449); 40 measurements were not validated by the algorithm due to connection errors.

References

    1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991 Aug;22(8):983–8.
    1. Vanbeselaere V, Truyers C, Elli S, Buntinx F, De Witte Harrie, Degryse J, Henrard S, Vaes B. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study. BMC Cardiovasc Disord. 2016 Mar 28;16:61. doi: 10.1186/s12872-016-0235-1.
    1. Santos JV, Pereira J, Pinto R, Castro PM, Azevedo E, Freitas A. Atrial Fibrillation as an Ischemic Stroke Clinical and Economic Burden Modifier: A 15-Year Nationwide Study. Value Health. 2017 Sep;20(8):1083–1091. doi: 10.1016/j.jval.2017.04.018.
    1. Johnsen SP, Dalby LW, Täckström T, Olsen J, Fraschke A. Cost of illness of atrial fibrillation: a nationwide study of societal impact. BMC Health Serv Res. 2017 Nov 10;17(1):714. doi: 10.1186/s12913-017-2652-y.
    1. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte Bart, Vardas P, ESC Scientific Document Group 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016 Oct 07;37(38):2893–2962. doi: 10.1093/eurheartj/ehw210.
    1. Hald J, Poulsen PB, Qvist I, Holm L, Wedell-Wedellsborg D, Dybro L, Frost L. Opportunistic screening for atrial fibrillation in a real-life setting in general practice in Denmark-The Atrial Fibrillation Found On Routine Detection (AFFORD) non-interventional study. PLoS One. 2017;12(11):e0188086. doi: 10.1371/journal.pone.0188086.
    1. Welton NJ, McAleenan A, Thom HH, Davies P, Hollingworth W, Higgins JP, Okoli G, Sterne JA, Feder G, Eaton D, Hingorani A, Fawsitt C, Lobban T, Bryden P, Richards A, Sofat R. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2017 May;21(29):1–236. doi: 10.3310/hta21290. doi: 10.3310/hta21290.
    1. Primo J, Gonçalves Helena, Macedo A, Russo P, Monteiro T, Guimarães João, Costa O. Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring. Rev Port Cardiol. 2017;36(7-8):535–546. doi: 10.1016/j.repc.2016.11.005.
    1. Turakhia MP, Shafrin J, Bognar K, Trocio J, Abdulsattar Y, Wiederkehr D, Goldman DP. Estimated prevalence of undiagnosed atrial fibrillation in the United States. PLoS One. 2018;13(4):e0195088. doi: 10.1371/journal.pone.0195088.
    1. Hobbs FDR, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, Raftery J, Davies M, Lip G. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005 Oct;9(40):iii–iv, ix. doi: 10.3310/hta9400.
    1. De Ridder B, Van Rompaey B, Kampen JK, Haine S, Dilles T. Smartphone Apps Using Photoplethysmography for Heart Rate Monitoring: Meta-Analysis. JMIR Cardio. 2018 Feb 27;2(1):e4. doi: 10.2196/cardio.8802.
    1. Jonathan E, Leahy M. Investigating a smartphone imaging unit for photoplethysmography. Physiol Meas. 2010 Nov;31(11):N79–83. doi: 10.1088/0967-3334/31/11/N01.
    1. Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, Gravenor MB. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation. 2017 Nov 07;136(19):1784–1794. doi: 10.1161/CIRCULATIONAHA.117.030583.
    1. Chan N, Choy C. Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram. Heart. 2017 Jan 01;103(1):24–31. doi: 10.1136/heartjnl-2016-309993.
    1. Li KHC, White FA, Tipoe T, Liu T, Wong MC, Jesuthasan A, Baranchuk A, Tse G, Yan BP. The Current State of Mobile Phone Apps for Monitoring Heart Rate, Heart Rate Variability, and Atrial Fibrillation: Narrative Review. JMIR Mhealth Uhealth. 2019 Feb 15;7(2):e11606. doi: 10.2196/11606.
    1. Proesmans T, Mortelmans C, Van Haelst R, Verbrugge F, Vandervoort P, Vaes B. Mobile Phone-Based Use of the Photoplethysmography Technique to Detect Atrial Fibrillation in Primary Care: Diagnostic Accuracy Study of the FibriCheck App. JMIR Mhealth Uhealth. 2019 Mar 27;7(3):e12284. doi: 10.2196/12284.
    1. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens ACJW, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb Stefan, Couper D, Harris TB, Soliman EZ, Stricker BHC, Gudnason V, Heckbert SR, Benjamin EJ. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013 Mar 18;2(2):e000102. doi: 10.1161/JAHA.112.000102.
    1. Tocchi C, Dixon J, Naylor M, Jeon S, McCorkle R. Development of a frailty measure for older adults: the frailty index for elders. J Nurs Meas. 2014;22(2):223–40. doi: 10.1891/1061-3749.22.2.223.
    1. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–83.
    1. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992 Jul 18;305(6846):160–4. doi: 10.1136/bmj.305.6846.160.
    1. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998 Nov;51(11):1055–68. doi: 10.1016/s0895-4356(98)00097-3.
    1. Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016;4:2050312116671725. doi: 10.1177/2050312116671725.
    1. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999 Sep;52(9):861–73. doi: 10.1016/s0895-4356(99)00071-2.
    1. Copay AG, Subach BR, Glassman SD, Polly DW, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007;7(5):541–6. doi: 10.1016/j.spinee.2007.01.008.
    1. Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA. 1989 Aug 18;262(7):925–30. doi: 10.1001/jama.262.7.925.
    1. Kruse C, Fohn J, Wilson N, Nunez Patlan E, Zipp S, Mileski M. Utilization Barriers and Medical Outcomes Commensurate With the Use of Telehealth Among Older Adults: Systematic Review. JMIR Med Inform. 2020 Aug 12;8(8):e20359. doi: 10.2196/20359.
    1. Hendrikx T, Hörnsten Rolf, Rosenqvist M, Sandström Herbert. Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population. BMC Cardiovasc Disord. 2013 Jun 10;13:41. doi: 10.1186/1471-2261-13-41.
    1. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213–20. doi: 10.2147/CLEP.S47385. doi: 10.2147/CLEP.S47385.
    1. Fischer SH, David D, Crotty BH, Dierks M, Safran C. Acceptance and use of health information technology by community-dwelling elders. Int J Med Inform. 2014 Sep;83(9):624–35. doi: 10.1016/j.ijmedinf.2014.06.005.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj